Gwenn M. Hansen

Gwenn M. Hansen

Chief Scientific OfficeratNurix Therapeutics· In proxies 2022–2025

Pay in FY2025+23% from the year before · Nurix Therapeutics stock -20.0% the same year

Gwenn M. Hansen was paid $2.5M in FY2025 (Nov), up 23%. Nurix Therapeutics stock fell 20.0% that year.

Pay$100 in the stock at the end of FY21 → $61
Pay is from the Summary Compensation Table of each Nurix Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Nurix TherapeuticsPublic company · 4 yr
    • Chief Scientific Officer2022 – Present · 4 yrStock in role -13%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?